Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ALIOF stock logo
ALIOF
ALIOF
$278.50
$278.50
$138.01
$286.30
$29.89BN/A924 shsN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$9.38
+1.8%
$9.97
$9.17
$14.14
N/A0.34190,263 shs172,822 shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$71.28
-0.8%
$69.57
$57.65
$94.80
$32.64B1.143.46 million shs6.21 million shs
Lonza Group Ag stock logo
LZAGY
Lonza Group
$68.22
+0.0%
$68.88
$53.02
$73.29
$49.27B1.1750,809 shs70,993 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ALIOF stock logo
ALIOF
ALIOF
0.00%0.00%0.00%0.00%0.00%
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
0.00%-3.89%-1.47%-10.50%-23.24%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.00%-1.34%+3.07%-12.75%-9.97%
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.00%-2.18%+0.04%+6.13%+27.82%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ALIOF stock logo
ALIOF
ALIOF
N/AN/AN/AN/AN/AN/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/AN/AN/AN/AN/AN/AN/AN/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
4.2308 of 5 stars
3.45.01.70.02.31.72.5
Lonza Group Ag stock logo
LZAGY
Lonza Group
1.0398 of 5 stars
0.03.00.80.01.20.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ALIOF stock logo
ALIOF
ALIOF
0.00
N/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
2.40
HoldN/AN/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.83
Moderate Buy$88.2723.84% Upside
Lonza Group Ag stock logo
LZAGY
Lonza Group
4.00
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest CLPBY, LZAGY, GEHC, and ALIOF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold
5/7/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/6/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$86.00 ➝ $78.00
5/5/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$74.00 ➝ $73.00
5/1/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$94.00 ➝ $82.00
5/1/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$103.00 ➝ $89.00
5/1/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$96.00 ➝ $85.00
4/30/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$105.00 ➝ $86.00
4/23/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$104.00 ➝ $88.00
4/14/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$95.00
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ALIOF stock logo
ALIOF
ALIOF
N/AN/AN/AN/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$3.93BN/AN/AN/AN/AN/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$19.67B1.66$5.78 per share12.34$18.53 per share3.85
Lonza Group Ag stock logo
LZAGY
Lonza Group
$7.47B6.60$2.00 per share34.05$14.76 per share4.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ALIOF stock logo
ALIOF
ALIOF
N/AN/A0.00N/AN/AN/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$734.56M$0.3031.2723.453.5716.38%27.29%9.40%8/19/2025 (Estimated)
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.99B$4.7515.0113.712.4011.02%24.95%6.38%7/30/2025 (Estimated)
Lonza Group Ag stock logo
LZAGY
Lonza Group
$722.43MN/A0.0031.442.31N/AN/AN/A7/23/2025 (Estimated)

Latest CLPBY, LZAGY, GEHC, and ALIOF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q2 2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.0874$0.06-$0.0274$0.06$7.02 billion$1.05 billion
4/30/2025Q1 2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.91$1.01+$0.10$1.23$4.66 billion$4.78 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ALIOF stock logo
ALIOF
ALIOF
N/AN/AN/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.080.85%N/A26.67%N/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.20%N/A2.95%1 Years
Lonza Group Ag stock logo
LZAGY
Lonza Group
$0.110.16%N/AN/AN/A

Latest CLPBY, LZAGY, GEHC, and ALIOF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/10/2025
Lonza Group Ag stock logo
LZAGY
Lonza Group
$0.10540.15%5/14/20255/15/20255/30/2025
5/16/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.03892.02%5/16/20255/19/20255/22/2025
3/27/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
quarterly$0.03500.17%4/25/20254/25/20255/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ALIOF stock logo
ALIOF
ALIOF
N/AN/AN/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
0.98
0.95
0.61
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.73
0.98
0.76
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.45
1.52
1.04

Institutional Ownership

CompanyInstitutional Ownership
ALIOF stock logo
ALIOF
ALIOF
N/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
82.06%
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.04%

Insider Ownership

CompanyInsider Ownership
ALIOF stock logo
ALIOF
ALIOF
N/A
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.27%
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
ALIOF stock logo
ALIOF
ALIOF
N/A107.33 millionN/ANot Optionable
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
16,875N/AN/ANot Optionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
53,000457.89 million456.65 millionOptionable
Lonza Group Ag stock logo
LZAGY
Lonza Group
18,000722.26 million721.76 millionNot Optionable

Recent News About These Companies

Lonza price target lowered to CHF 670 from CHF 710 at Barclays
Lonza: Well Equipped In The U.S., Buy Confirmed
Lonza price target raised to CHF 640 from CHF 610 at RBC Capital
LZAGF Lonza Group AG
Lonza downgraded to Equal Weight from Overweight at Morgan Stanley
Lonza price target raised to CHF 744 from CHF 645 at Deutsche Bank
Lonza price target raised to CHF 710 from CHF 630 at Barclays
Lonza price target raised to CHF 680 from CHF 640 at Berenberg
Kepler Capital Sticks to Its Buy Rating for Lonza Group Ltd (LONN)

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALIOF stock logo

ALIOF OTCMKTS:ALIOF

$278.50 0.00 (0.00%)
As of 09/27/2022

Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.

Coloplast A/S stock logo

Coloplast A/S OTCMKTS:CLPBY

$9.38 +0.17 (+1.85%)
As of 06/20/2025 03:58 PM Eastern

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$71.28 -0.61 (-0.85%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$71.58 +0.30 (+0.42%)
As of 06/20/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Lonza Group stock logo

Lonza Group OTCMKTS:LZAGY

$68.22 +0.01 (+0.01%)
As of 06/20/2025 03:58 PM Eastern

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.